MedGenome

Bengaluru, India Founded: 2013 • Age: 13 yrs
DNA sequencing, bioinformatics, and multiomics services are provided.

About MedGenome

MedGenome is a Healthcare company based in Bengaluru (India) founded in 2013 by Mahesh Pratapneni. DNA sequencing, bioinformatics, and multiomics services are provided. MedGenome has raised $264.5 million across 10 funding rounds from investors including HDFC, HDFC Mutual Fund and International Finance Corporation. The company has 883 employees. MedGenome has completed 4 acquisitions, including Lifecode, Medcare Diagnostics and Prognosis. Its chief executive, as recorded, is Mahesh Pratapneni. Its website medgenome.com draws about 47 thousand monthly visits. Its Indian entity Medgenome Labs Limited reported revenue of β‚Ή407 Cr. MedGenome offers products and services including Sequencing Services and Bioinformatics Services. Its focus areas include Clinical Laboratory Chains, Pathology and Genetic Test.

Company details

MedGenome was founded in 2013 and is headquartered in Bengaluru, India, within the genomics and biotechnology sector. A range of services is offered, including whole genome and exome sequencing, single-cell sequencing, spatial transcriptomics, and immune profiling. Bioinformatics assistance, such as analysis pipelines and data visualization tools, is provided to support research efforts in rare diseases, cancer, and antibody discovery.

  • Headquarters Bengaluru, India
  • Employees 883
  • Founders Mahesh Pratapneni
  • Sectors
    Healthcare
  • Website category Health · Biotechnology and Pharmaceuticals
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website medgenome.com
  • Social LinkedIn X Facebook
  • Legal Name Medgenome Labs Limited
  • Date of Incorporation 08 Apr, 2013
  • Jurisdiction Bangalore, Karnataka, India
Operational Areas
Key Metrics
  • Annual Revenue
    ₹407 Cr

    FY 2025 · +36% YoY

  • Net Profit
    ₹46.77 Cr

    FY 2025 · 11% margin

  • EBITDA
    ₹81.03 Cr

    FY 2025 · 20% margin

  • Total Equity Funding
    $264.5M (USD)

    in 10 rounds

  • Latest Funding Round
    $47.5M (USD), Series E

    Jul 2025

  • Investors
    HDFC

    & 24 more

  • Employee Count
    883
  • Investments & Acquisitions
    Lifecode

    & 3 more

Products & Services of MedGenome

MedGenome offers a comprehensive portfolio of products and services, including Sequencing Services and Bioinformatics Services.

Sequencing Services
Genomics

Offers DNA, RNA, and single-cell sequencing for research applications.

Bioinformatics Services
Data Analysis

Provides analysis of genomic data for insights and publications.

Funding Insights of MedGenome

MedGenome has successfully raised a total of $264.5M across 10 strategic funding rounds. The most recent funding activity was a Series E round of $47.5 million completed in July 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $264.5M
  • Total Rounds 10
  • Last Round Series E β€” $47.5M
  • First Round $1.5M

    (Aug 2013)

  • Investors Count 25

All 10 funding rounds of MedGenome with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jul 2025$47.5MSeries E–Maj Invest
Aug 2022$50MSeries D–Novo Holdings
Jul 2021$16.5MSeries D–Kemwel
Apr 2020$55MSeries D–LeapFrog Investments
Jan 2019$161,163Grant––
Mar 2018$40MSeries C–HDFC, Rajesh Agrawal
Aug 2017$30MSeries C–Lakshami Narayan, Sofina
Jul 2015$20MSeries B–Peak XV Partners
–
Jun 2014$4MSeries A–Mahesh Pratapneni, Kartik Kumaramangalam
Aug 2013$1.5MSeed–Emerge Ventures
–
Valuation history

25 investors in total: 15 institutional and 10 angel.

Investors in MedGenome

MedGenome has secured backing from 25 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include HDFC, HDFC Mutual Fund and International Finance Corporation.

All
Venture Fund
Institutional
Angel
InvestorDescriptionFounded YearDomainLocation
Private equity and venture capital fund focused on the healthcare sector
novoholdings.dkHellerup, Denmark
Venture capital investments are provided by Sofina to emerging companies.
sofinagroup.comBrussels, Belgium
IFC is focused on private sector development in emerging markets.
1956ifc.org
Private equity fund focused on banking, finance, healthcare, and multiple sectors
2007leapfroginvest.comJohannesburg, South Africa
Venture capital firm investing in startups and providing support programs.
2000peakxv.comBengaluru, India
VC firm investing in India
2011zodius.comMumbai, India
Private investment arm of Kris Gopalakrishnan Family Office.
2014pratithi.comBengaluru, India
Growth stage tech and life sciences focused VC firm investing primarily in India and the US
emergeout.comSingapore, Singapore
Private equity investments are directed toward ESG-focused companies.
majinvest.comCopenhagen, Denmark
Educational and entertainment products for children are created and offered.
1995leapfrog.comEmeryville, United States
Premium access

Investor details for MedGenome

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Medgenome Labs Limited (MedGenome)

Medgenome Labs Limited is the primary company behind MedGenome. The board of Medgenome Labs Limited currently have 6 directors; the longest-serving is Mahesh Pratapneni, appointed in 2014. 7 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Mahesh Pratapneni
DIN 03505338
Director30 Sep 201412 yrs 1 moMedgenome Labs Limited
Surajit Chakrabartty
DIN 07824688
CFO01 Dec 201411 yrs 11 moMedgenome Labs Limited
Shankar Mahadevappa Prasad
DIN 06489411
Director24 Dec 20187 yrs 10 moMedgenome Labs Limited
Prasad Bhagwan Shejale
DIN 01685573
Director30 Sep 20197 yrs 1 moMedgenome Labs Limited
Suryaprakasam Vedam Lakshmi Ramprasad
DIN 09618800
CEO16 Nov 20232 yrs 11 moMedgenome Labs Limited
Navjeewan Jatinder Khosla
DIN 10659948
Director07 Nov 20242 yrsMedgenome Labs Limited

People of MedGenome

206 people are tracked at MedGenome (21 in leadership, 5 in board & advisors, 180 in team); the tracked headcount is 883.

NameRoleGroup
Co-Founder & Co-CEOLeadership
CEOLeadership
Suruchi Aggarwal
Head - Scientific AffairsLeadership
Vipin Dwivedi
Deputy General ManagerLeadership
Mohana Sundaram Haridas
Associate DirectorLeadership
Sakthivel Murugan
VP, Lab Operations and Genomic Medicine OperationsLeadership
Mohit Bhardwaj
Associate DirectorLeadership
Harsha Gowda
Sr. Principal Scientist & Director of Research & DevelopmentLeadership
Oommen K Mathew
Associate Director Bioinformatics EngineeringLeadership
Somasekar Seshagiri
Chief Science OfficerLeadership
CFO, IndiaLeadership
Balaji Rajashekar
Director - Clinical BioinformaticsLeadership
Dr. Meenal Agarwal (MD, DM)
Director - Clinical GeneticsLeadership
Vivekananth Murali
Business Head - Academia And Corporate Research ServicesLeadership
Dr.prasanna Kumar (Docprass)
Director - Research CollaborationsLeadership
Soumittra N
Disease Head, OphthalmologyLeadership
Gunisha Pasricha
Associate Director, Research ServicesLeadership
Angelica Lavallee
Vice President - MultiomicsLeadership
Ravi Gupta
VP, BioinformaticsLeadership
Marco Corbo
Senior Bioinformatics Scientist And Director Of BioinformaticsLeadership

186 more people are available in the full profile.

Premium access

Complete people profiles for MedGenome

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of MedGenome

Figures of Medgenome Labs Limited, the primary company behind MedGenome, for FY 2025. Revenue was ₹407 Cr (+36% year on year). Net profit was ₹46.77 Cr (11% margin). EBITDA was ₹81.03 Cr (20% margin). Revenue has grown at a compounded annual rate of +22% over three years and +30% over five years.

  • ₹407 CrRevenue · FY 2025 · +36% YoY
  • ₹46.77 CrNet profit · 11% margin
  • ₹81.03 CrEBITDA · 20% margin
  • ₹5.91 CrPaid-up capital
  • 883Employees (provident fund records)
  • +22%Revenue CAGR, 3 years
  • +30%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Medgenome Labs Limited are on its company page.

Premium access

Detailed financial statements for MedGenome

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by MedGenome

MedGenome has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Lifecode, Medcare Diagnostics and Prognosis.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Offers diagnostic imaging services like PET-CT and CT scans in Mumbai.
medcarediagnostics.comMumbai, India2013Mar 2026β€’β€’β€’β€’
Diagnostic services in cardiology, radiology, pathology, and imaging are offered.
prlworld.comDelhi, India2002May 2023β€’β€’β€’β€’
Provider of radiology, pathology, and other services
tridentdiagnostics.comBengaluru, India2016Nov 2021β€’β€’β€’β€’
Molecular tumor profiling panels for solid tumors are developed.
lifecodehealth.comFoster, United States2012Feb 2016β€’β€’β€’β€’
Premium access

Complete acquisition details for MedGenome

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of MedGenome

7 dated milestones of MedGenome across 13 years, from founding to its latest funding, stage changes and deals.

  1. Founded MedGenome is founded.
  2. Funding First funding round of $1.5M.
  3. Acquisition Acquires Lifecode.
  4. Acquisition Acquires Trident Diagnostics.
  5. Acquisition Acquires Prognosis.
  6. Funding Latest funding round, Series E, of $47.5M.
  7. Acquisition Acquires Medcare Diagnostics.

Web traffic of MedGenome

The website of MedGenome (medgenome.com) receives about 47.4K visits a month and ranks #389,183 among all websites worldwide, #336 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    47.4K

    ▼ 28.4% vs previous month

  • Unique visitors
    20.5K

    per month

  • Global rank
    #389,183

    among all websites

  • Category rank
    #336

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with MedGenome. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
genetech.co.in
100%
2.4K#9,938,815View details
niih.org.in
88%
#1,293,599View details
medisapiens.com
88%
View details
centogene.com
75%
28.5KView details
genetrack.in
genetrack.in
66%
#1,807,695–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 30 similar websites and full traffic analytics for MedGenome

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 30 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Diagnostics Laboratories

3 companies that operate in the same segment as MedGenome (Diagnostics Laboratories) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Diagnostic testing centers for pathology and health screenings are operated.
1996Mumbai, Maharashtra, IndiaUSD 63.59 MUSD 90.17 M1,979
Chain of pathology and radiology labs
1949Gurugram, Haryana, IndiaUSD 13.9 MUSD 294.49 M5,310
Home-based diagnostic tests are booked via an online platform.
2018Noida, Uttar Pradesh, IndiaUSD 116.42 MUSD 41.86 M2,308
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Medgenome

Premium access

Complete news archive for MedGenome

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about MedGenome

MedGenome was founded in 2013.

MedGenome is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.

Mahesh Pratapneni is the CEO of MedGenome, as recorded in our data. They have also founded this company.

MedGenome is a funded company, having raised a total of $264.5M across 10 funding rounds to date. The company's 1st funding round was a Seed of $1.5M, raised on Aug 2013.

MedGenome has 883 employees.

The primary company behind MedGenome, Medgenome Labs Limited, reported revenue of β‚Ή407 Cr for FY 2025, up 36% year on year.

MedGenome was founded in 2013 and is headquartered in Bengaluru, India, within the genomics and biotechnology sector. A range of services is offered, including whole genome and exome sequencing, single-cell sequencing, spatial transcriptomics, and immune profiling. Bioinformatics assistance, such as analysis pipelines and data visualization tools, is provided to support research efforts in rare diseases, cancer, and antibody discovery.

MedGenome offers Sequencing Services and Bioinformatics Services.

MedGenome has made 4 acquisitions, including Lifecode, Medcare Diagnostics, and Prognosis.

MedGenome has 25 investors. Key investors include HDFC, HDFC Mutual Fund, International Finance Corporation, LeapFrog, and HDFC Life.

MedGenome operates through Medgenome Labs Limited.

The legal entities of MedGenome currently have 6 directors, including Suryaprakasam Vedam Lakshmi Ramprasad, Surajit Chakrabartty, Navjeewan Jatinder Khosla and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available